Vista Capital Partners, Inc. Amgen Inc Transaction History

Vista Capital Partners, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $177,215 - $211,031	-819 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $192,178 - $213,718	819 New	819 $208,000
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $158,731 - $210,520	-871 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $164,801 - $211,827	871 New	871 $209,000
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $209,377 - $236,045	-1,130 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $187,636 - $210,756	1,130 New	1,130 $208,000
Q1 2018 Apr 17, 2018	SELL	$169.43 - $198.0 $312,937 - $365,706	-1,847 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $308,984 - $352,777	1,847	1,847 $344,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Vista Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Vista Capital Partners, Inc. with notifications on news.